{"id":"bt5528","safety":{"commonSideEffects":[{"rate":"20-30%","effect":"Fatigue"},{"rate":"15-25%","effect":"Nausea"},{"rate":"10-20%","effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL5314953","moleculeType":"Protein","molecularWeight":"4402.25"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By blocking the interaction between CD47 and SIRPα, BT5528 aims to prevent tumor cells from evading immune surveillance. This mechanism is thought to enhance the body's immune response against cancer cells.","oneSentence":"BT5528 is a small molecule inhibitor of the CD47/SIRPα axis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:58:51.356Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Relapsed or refractory multiple myeloma"}]},"trialDetails":[{"nctId":"NCT07450859","phase":"PHASE2","title":"A Study of BT5528 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)","status":"RECRUITING","sponsor":"BicycleTx Limited","startDate":"2026-03","conditions":"Pancreatic Ductal Adenocarcinoma (PDAC)","enrollment":39},{"nctId":"NCT04180371","phase":"PHASE1, PHASE2","title":"Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression","status":"ACTIVE_NOT_RECRUITING","sponsor":"BicycleTx Limited","startDate":"2019-11-07","conditions":"Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer","enrollment":288}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"BT5528","genericName":"BT5528","companyName":"BicycleTx Limited","companyId":"bicycletx-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"BT5528 is a small molecule inhibitor of the CD47/SIRPα axis. Used for Relapsed or refractory multiple myeloma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}